Skip to main content

Single Gen Z women outpace Gen Z men to homeownership despite overall decline in first-time buyers

LOS ANGELES (AP) — Single Gen Z women are outpacing their male counterparts when it comes to buying a home.

They accounted for 35% of all homebuyers in their generation, while single Gen Z men represented 18%, according to survey data from the National Association of Realtors.

NAR surveyed people who bought a home between July 2024 and June 2025. The survey included homebuyers from several generations, from Gen Z, ages 18-26, to the Silent Generation, ages 80 to 100. No other generation had a bigger share of single women homebuyers than Gen Z.

Overall Gen Zers, which the survey defines as those born between 1999 and 2011, still only made up 4% of all homebuyers during the survey period. And at the time of the survey, the share of U.S. homes bought by first-time buyers of all ages sank to the lowest level on record going back to 1981.

First-time buyers often don’t have equity from a previous home to put toward a down payment. That was the situation for Bri LaFluer. After years of socking away half her pay, working two jobs and aided by a slowing housing market, she bought her own home in 2023 at the age of 24.

“I’ve always been a really independent person and I just wanted my own place to have peace and quiet by myself,” said LaFluer, now 27.

Her home search began in 2021, but historically low mortgage rates made the market ultra competitive, which turbocharged prices. Two years later she finally landed a house in Baldwinsville, N.Y., about 15 miles from Syracuse, that was built in 1900 and has three bedrooms and 1.5-baths and a big yard. She got it for $175,000.

“I feel like it was meant to be and this just ended up being the perfect house for me and my dogs,” she said.

A content creator for a video game company, LaFluer lived with her mom and paid a modest rent, which helped her save up faster for the $20,000 down payment.

The NAR survey data are the latest sign that single women overall are becoming homeowners at greater rates than single men. Gen Z homebuyers are much more likely than homebuyers in all other generations to be unmarried. But single women across the generations made up a quarter of all homebuyers in the July 2024-June 2025 period, according to NAR. Single men, meanwhile, accounted for 11% of all home purchases.

This has been a longstanding trend going back at least to 1981. In 2006, at the height of the mid-2000s housing boom, the share of homes bought by single women peaked at 22%, according to NAR. For single men, their share of homeownership peaked at 12% in 2010.

Experts say there is no one-size-fits-all answer to why across the generations single women outnumber single men as homeowners.

Women now are outpacing men in college attendance, which can lead to higher incomes, said Jessica Lautz, NAR’s deputy chief economist.

They tend to have a strong desire for homeownership as a way to secure their independence, something they historically could not easily do alone.

“It wasn’t until the 1970s where women were legally protected to have a mortgage on their own,” Lautz said. “And they have embraced this and been very strongly embracing this.”

Aspiring Gen Z homeowners face a number of challenges to affording a home: They’re typically just getting started in their careers, with their best income-earning years ahead. They are unlikely to be married and may have student loans to pay off.

Their median annual income of $76,000, as of 2024, also was the lowest compared to homebuyers from all other generations, according to NAR.

Years of soaring home prices have further stretched the limits of affordability. While home price growth has slowed and prices have fallen in many metro areas, prices are mostly still rising. The median U.S. home sales price stood at $417,700 last month, up 0.9% from a year earlier, according to NAR.

Still, Gen Z homebuyers are also more likely to receive financial help from family, and many are savvy about looking into community grants or other payment assistance programs for first-time homebuyers. And 1 in 10 tapped their 401(k) retirement savings plan to put toward their down payment, according to NAR.

Other home shoppers have no recourse but to save up on their own.

That’s what Mariah Berry focused on when many of her fellow college grads were going out and living it up.

“I did not go out and was driving an old beat-up car,” said Berry, a social media content creator. “It was not fun.”

The penny-pinching paid off in 2023, when Berry bought her two-bedroom, one-bath home in Charleston, Tennessee, a small town about 45 miles outside of Chattanooga. She was just 23.

Berry had always wanted to be a homeowner, but the goal took on more urgency after a period when she and her boyfriend were bouncing between living in short-term rentals or couch surfing with friends.

Berry got her home, one of two units in a ranch-style duplex, for $218,000. She financed the balance after making a $7,000 down payment with a 30-year mortgage at 6% interest.

“I do think it’s pretty frickin’ awesome that I’m a homeowner and that I became a homeowner at 23,” she said. “I will say that after I put in the offer, I wanted to puke. I was like, ’Oh my God, did I do the right thing?’”

Berry’s now looking at the possibility of buying the other half of the duplex some day.

“That could be a good opportunity for us to have and like rent out half of it,” she said.

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story